Leverette (Ethinylestradiol, Levonorgestrel | Lactose)

Ethinylestradiol and levonorgestrel act on the hypothalamic‑pituitary‑ovarian axis. Ethinylestradiol provides estrogenic activity while levonorgestrel supplies progestogenic effects. Together they suppress gonadotropin‑releasing hormone, lower FSH and LH levels, prevent ovulation, thicken cervical mucus, and alter the endometrium, creating multiple barriers to fertilization and implantation.

The dosing regimen for Leverette is determined by the prescribing clinician. Typically, patients are instructed to take one tablet daily at the same time each day for a 21‑day cycle followed by a hormone‑free interval, but the exact schedule should be confirmed with a qualified healthcare professional.

Leverette is contraindicated during pregnancy and should not be started or continued by women who are pregnant. While limited data exist for breastfeeding, most guidelines advise caution; the benefits and risks should be evaluated by a healthcare provider, and alternative contraception may be recommended.

To order Leverette, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Leverette contains the standard dose combination of ethinylestradiol and levonorgestrel, a widely used progestin. Its efficacy and safety profile are comparable to other COCs that use the same active ingredients. Differences among products often relate to pill formulation, estrogen dose, or additional inactive ingredients, which may affect tolerability for individual patients.

Leverette tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container. Protect them from moisture, excessive heat, and direct sunlight. Keep the medication out of reach of children and do not use tablets that appear discoloured or damaged.

Leverette is taken orally as a tablet. Swallow each tablet whole with water, preferably at the same time each day. Do not split, crush, or chew the tablet, as this could affect absorption and reduce contraceptive effectiveness.

The most serious risks include venous thromboembolism, arterial thrombosis such as stroke or myocardial infarction, and severe allergic reactions (anaphylaxis). Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should be closely monitored or may need alternative contraception.

Leverette should not be used by women who are pregnant, have known or suspected breast cancer, have a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or are smokers over 35 years of age. It is also contraindicated in individuals with known hypersensitivity to any component of the tablet.